A detailed history of Investment Management Corp Of Ontario transactions in Biogen Inc. stock. As of the latest transaction made, Investment Management Corp Of Ontario holds 4,870 shares of BIIB stock, worth $725,727. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,870
Previous 3,270 48.93%
Holding current value
$725,727
Previous $758,000 24.54%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $302,512 - $378,880
1,600 Added 48.93%
4,870 $944,000
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $171,468 - $213,048
900 Added 37.97%
3,270 $758,000
Q1 2024

May 15, 2024

SELL
$212.02 - $267.71 $3.86 Million - $4.87 Million
-18,187 Reduced 88.47%
2,370 $511,000
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $4.58 Million - $5.51 Million
20,557 New
20,557 $5.32 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Investment Management Corp Of Ontario Portfolio

Follow Investment Management Corp Of Ontario and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Management Corp Of Ontario, based on Form 13F filings with the SEC.

News

Stay updated on Investment Management Corp Of Ontario with notifications on news.